US Stock MarketDetailed Quotes

Tenon Medical (TNON)

Watchlist
  • 0.7200
  • -0.0940-11.55%
Close May 13 15:59 ET
  • 0.7201
  • +0.0001+0.01%
Post 19:35 ET
8.13MMarket Cap-0.72P/E (TTM)

Tenon Medical (TNON) Income Statement

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(FY)Dec 31, 2025
(Q4)Dec 31, 2025
(Q3)Sep 30, 2025
(Q2)Jun 30, 2025
(Q1)Mar 31, 2025
(FY)Dec 31, 2024
(Q4)Dec 31, 2024
(Q3)Sep 30, 2024
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
Total revenue
20.35%3.94M
92.34%1.48M
32.24%1.17M
-37.40%564K
0.97%726K
11.92%3.28M
-4.70%770K
-6.04%887K
21.27%901K
66.05%719K
Operating revenue
20.35%3.94M
92.34%1.48M
32.24%1.17M
-37.40%564K
0.97%726K
11.92%3.28M
-4.70%770K
-6.04%887K
21.27%901K
66.05%719K
Cost of revenue
1.28%1.59M
11.27%464K
-14.71%400K
-25.99%319K
61.85%403K
-7.17%1.57M
67.47%417K
14.67%469K
-21.49%431K
-48.13%249K
Gross profit
37.81%2.36M
188.10%1.02M
84.93%773K
-47.87%245K
-31.28%323K
37.87%1.71M
-36.85%353K
-21.87%418K
142.27%470K
1,100.00%470K
Operating expense
-2.11%15.15M
10.12%3.88M
14.64%4.17M
-28.56%3.1M
0.60%4M
-8.79%15.48M
-4.70%3.53M
-7.16%3.63M
-3.85%4.34M
-17.83%3.98M
Selling and administrative expenses
0.99%13M
13.49%3.36M
25.57%3.74M
-28.48%2.6M
0.06%3.31M
-6.74%12.87M
-1.73%2.96M
-6.30%2.98M
0.53%3.63M
-17.43%3.31M
-Selling and marketing expense
17.95%6.03M
61.24%1.72M
26.90%1.54M
-22.72%1.12M
19.26%1.65M
-24.62%5.11M
-20.42%1.07M
-20.63%1.21M
-23.10%1.45M
-31.84%1.38M
-General and administrative expense
-10.17%6.98M
-13.50%1.63M
24.66%2.2M
-32.30%1.48M
-13.71%1.66M
10.50%7.77M
13.32%1.89M
6.97%1.76M
26.21%2.19M
-2.68%1.93M
Research and development costs
-17.44%2.15M
-7.38%527K
-34.86%428K
-28.95%503K
3.29%691K
-17.70%2.6M
-17.66%569K
-10.85%657K
-21.42%708K
-19.78%669K
Operating profit
7.08%-12.79M
9.68%-2.87M
-5.51%-3.39M
26.21%-2.86M
-4.88%-3.68M
12.47%-13.77M
-1.02%-3.17M
4.83%-3.22M
10.41%-3.87M
28.24%-3.51M
Net non-operating interest income expense
0
0
0
0
0
-61.90%-34K
0
0
0
-34K
Non-operating interest expense
--0
--0
--0
--0
--0
61.90%34K
--0
--0
--0
--34K
Other net income (expense)
85.83%236K
-60.47%34K
70.97%53K
91.30%88K
269.44%61K
-23.95%127K
258.33%86K
-38.00%31K
24.32%46K
-164.29%-36K
Gain on sale of security
28.96%236K
-60.47%34K
70.97%53K
125.64%88K
125.93%61K
9.58%183K
258.33%86K
-38.00%31K
5.41%39K
-51.79%27K
Other non- operating income (expenses)
----
----
----
----
----
---56K
--0
----
--7K
---63K
Income before tax
8.17%-12.56M
8.26%-2.83M
-4.87%-3.34M
27.63%-2.77M
-1.12%-3.62M
12.25%-13.67M
1.50%-3.09M
4.44%-3.18M
10.71%-3.83M
25.96%-3.58M
Income tax
Net income
8.17%-12.56M
8.26%-2.83M
-4.87%-3.34M
27.63%-2.77M
-1.12%-3.62M
12.25%-13.67M
1.50%-3.09M
4.44%-3.18M
10.71%-3.83M
25.96%-3.58M
Net income continuous Operations
8.17%-12.56M
8.26%-2.83M
-4.87%-3.34M
27.63%-2.77M
-1.12%-3.62M
12.25%-13.67M
1.50%-3.09M
4.44%-3.18M
10.71%-3.83M
25.96%-3.58M
Minority interest income
Net income attributable to the parent company
8.17%-12.56M
8.26%-2.83M
-4.87%-3.34M
27.63%-2.77M
-1.12%-3.62M
12.25%-13.67M
1.50%-3.09M
4.44%-3.18M
10.71%-3.83M
25.96%-3.58M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders
8.17%-12.56M
8.26%-2.83M
-4.87%-3.34M
27.63%-2.77M
-1.12%-3.62M
12.25%-13.67M
1.50%-3.09M
4.44%-3.18M
10.71%-3.83M
25.96%-3.58M
Basic earnings per share
84.90%-1.7
77.63%-0.22
88.98%-0.4
95.59%-0.36
89.92%-1.01
83.60%-11.26
81.99%-0.9835
68.95%-3.63
68.90%-8.16
70.87%-10.02
Diluted earnings per share
84.90%-1.7
77.63%-0.22
88.98%-0.4
95.59%-0.36
89.92%-1.01
83.60%-11.26
81.99%-0.9835
68.95%-3.63
68.90%-8.16
70.87%-10.02
Dividend per share
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
Unqualified Opinion with Explanatory Notes
--
--
--
--
Unqualified Opinion with Explanatory Notes
--
--
--
--
(FY)Dec 31, 2025(Q4)Dec 31, 2025(Q3)Sep 30, 2025(Q2)Jun 30, 2025(Q1)Mar 31, 2025(FY)Dec 31, 2024(Q4)Dec 31, 2024(Q3)Sep 30, 2024(Q2)Jun 30, 2024(Q1)Mar 31, 2024
Total revenue 20.35%3.94M92.34%1.48M32.24%1.17M-37.40%564K0.97%726K11.92%3.28M-4.70%770K-6.04%887K21.27%901K66.05%719K
Operating revenue 20.35%3.94M92.34%1.48M32.24%1.17M-37.40%564K0.97%726K11.92%3.28M-4.70%770K-6.04%887K21.27%901K66.05%719K
Cost of revenue 1.28%1.59M11.27%464K-14.71%400K-25.99%319K61.85%403K-7.17%1.57M67.47%417K14.67%469K-21.49%431K-48.13%249K
Gross profit 37.81%2.36M188.10%1.02M84.93%773K-47.87%245K-31.28%323K37.87%1.71M-36.85%353K-21.87%418K142.27%470K1,100.00%470K
Operating expense -2.11%15.15M10.12%3.88M14.64%4.17M-28.56%3.1M0.60%4M-8.79%15.48M-4.70%3.53M-7.16%3.63M-3.85%4.34M-17.83%3.98M
Selling and administrative expenses 0.99%13M13.49%3.36M25.57%3.74M-28.48%2.6M0.06%3.31M-6.74%12.87M-1.73%2.96M-6.30%2.98M0.53%3.63M-17.43%3.31M
-Selling and marketing expense 17.95%6.03M61.24%1.72M26.90%1.54M-22.72%1.12M19.26%1.65M-24.62%5.11M-20.42%1.07M-20.63%1.21M-23.10%1.45M-31.84%1.38M
-General and administrative expense -10.17%6.98M-13.50%1.63M24.66%2.2M-32.30%1.48M-13.71%1.66M10.50%7.77M13.32%1.89M6.97%1.76M26.21%2.19M-2.68%1.93M
Research and development costs -17.44%2.15M-7.38%527K-34.86%428K-28.95%503K3.29%691K-17.70%2.6M-17.66%569K-10.85%657K-21.42%708K-19.78%669K
Operating profit 7.08%-12.79M9.68%-2.87M-5.51%-3.39M26.21%-2.86M-4.88%-3.68M12.47%-13.77M-1.02%-3.17M4.83%-3.22M10.41%-3.87M28.24%-3.51M
Net non-operating interest income expense 00000-61.90%-34K000-34K
Non-operating interest expense --0--0--0--0--061.90%34K--0--0--0--34K
Other net income (expense) 85.83%236K-60.47%34K70.97%53K91.30%88K269.44%61K-23.95%127K258.33%86K-38.00%31K24.32%46K-164.29%-36K
Gain on sale of security 28.96%236K-60.47%34K70.97%53K125.64%88K125.93%61K9.58%183K258.33%86K-38.00%31K5.41%39K-51.79%27K
Other non- operating income (expenses) -----------------------56K--0------7K---63K
Income before tax 8.17%-12.56M8.26%-2.83M-4.87%-3.34M27.63%-2.77M-1.12%-3.62M12.25%-13.67M1.50%-3.09M4.44%-3.18M10.71%-3.83M25.96%-3.58M
Income tax
Net income 8.17%-12.56M8.26%-2.83M-4.87%-3.34M27.63%-2.77M-1.12%-3.62M12.25%-13.67M1.50%-3.09M4.44%-3.18M10.71%-3.83M25.96%-3.58M
Net income continuous Operations 8.17%-12.56M8.26%-2.83M-4.87%-3.34M27.63%-2.77M-1.12%-3.62M12.25%-13.67M1.50%-3.09M4.44%-3.18M10.71%-3.83M25.96%-3.58M
Minority interest income
Net income attributable to the parent company 8.17%-12.56M8.26%-2.83M-4.87%-3.34M27.63%-2.77M-1.12%-3.62M12.25%-13.67M1.50%-3.09M4.44%-3.18M10.71%-3.83M25.96%-3.58M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders 8.17%-12.56M8.26%-2.83M-4.87%-3.34M27.63%-2.77M-1.12%-3.62M12.25%-13.67M1.50%-3.09M4.44%-3.18M10.71%-3.83M25.96%-3.58M
Basic earnings per share 84.90%-1.777.63%-0.2288.98%-0.495.59%-0.3689.92%-1.0183.60%-11.2681.99%-0.983568.95%-3.6368.90%-8.1670.87%-10.02
Diluted earnings per share 84.90%-1.777.63%-0.2288.98%-0.495.59%-0.3689.92%-1.0183.60%-11.2681.99%-0.983568.95%-3.6368.90%-8.1670.87%-10.02
Dividend per share
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions Unqualified Opinion with Explanatory Notes--------Unqualified Opinion with Explanatory Notes--------
Market Insights
China Concept Stocks
View More
Middle East conflict spreads to the stock market! How should investors respond?
According to Axios, on Sunday local time, Trump rejected Iran's latest ceasefire proposal, prompting a sharp response from Iran: no one woul Show More